Roche Applied Science, a business area of Hoffmann-La Roche, develops and produces innovative tools for the life science research market and for industrial use. During the last 15 years, the company shifted from only providing biochemical reagents and kits to also manufacturing analytical instrument systems for sample preparation, real-time PCR, sequencing, arrays, and cell analytics.
The life science market is advancing quickly, and innovative products that meet the needs of researchers are the key to success. Roche Applied Science’s product lines are well positioned for a long-term future in the marketplace.
Some time ago, Roche acquired NimbleGen and 454 Life Sciences. Both companies complemented Applied Sciences’ workflows, especially for pharmaceutical research: DNA sequencing enables the user to identify content for arrays, qPCR can be used to validate results out of array analyses. Another workflow example is NimbleGen’s sequence capture arrays enriching genomic regions for subsequent DNA sequencing. The technologies of NimbleGen and 454 Life Sciences have contributed to Applied Science’s worldwide reputation as a provider of innovative world-class technology.
Another part of Roche Applied Science’s business is Biochemicals/Custom Biotech. Applied Science’s biochemical products have a loyal following in the research community. Roche is also regarded as a high-quality raw materials provider for the life sciences, diagnostics, and pharmaceutical industry. Traditional Applied Science products are benefiting greatly from marketing interactions with Custom Biotech, which is targeting the industrial customer segment, and vice versa.